NCT06560580View on ClinicalTrials.gov

Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

July 20, 2023

Study Completion Date

July 25, 2024

Conditions
Dry Eye Disease
Interventions
DRUG

3% Diquafosol Sodium Eye Drops

Each patient was prescribed 3% (5 mL: 150 mg) diquafosol sodium eye drops \[Diquas®, provided by Santen Pharmaceutical (China) Co., Ltd.\], recommended to instill one drop six times daily for 3 months. Follow-up examinations were conducted at baseline, 1 month, and 3 months after treatment initiation.

Trial Locations (1)

Unknown

Tianjin Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Eye Hospital

OTHER

NCT06560580 - Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye | Biotech Hunter | Biotech Hunter